Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Aconitase deficiency is characterized by myopathy with severe exercise intolerance and deficiencies of skeletal muscle succinate dehydrogenase and aconitase.
Features include always present findings: Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Low muscle tone (hypotonia), Distal muscle weakness, and Low red blood cell count (anemia) and others; and sometimes findings: Rhabdomyolysis. 32 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 10 | Myopathy, Low muscle tone (hypotonia), Muscle spasm |
ISCU encodes iron-sulfur cluster assembly enzyme (167 aa). Mitochondrial scaffold protein, of the core iron-sulfur cluster (ISC) assembly complex, that provides the structural architecture on which the [2Fe-2S] clusters are assembled. Highest expression in Adrenal Gland (227.3 TPM) and Artery Tibial (216.8 TPM).
Hereditary myopathy with lactic acidosis due to ISCU deficiency is associated with mutations in the ISCU gene on chromosome 12.
The ISCU protein participates in 2 Iron:FXN:NFS1:ISD11:ISCU, FXN:NFS1:ISD11:ISCU:2Fe-2S Cluster, and FXN:NFS1:ISD11:ISCU assembles 2Fe-2S iron-sulfur cluster pathways.
ISCU is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for ISCU is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 18 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hereditary myopathy with lactic acidosis due to ISCU deficiency.
2 publications have been identified in PubMed for hereditary myopathy with lactic acidosis due to ISCU deficiency. Research spans Review / Meta-Analysis (50%) and Case Report / Case Series (50%).
Adorisio R (2025). [PMID: 40678571](https://pubmed.ncbi.nlm.nih.gov/40678571/). *Front Cardiovasc Med*. [Review / Meta-Analysis]
Rusecka JM (2025). [PMID: 40529812](https://pubmed.ncbi.nlm.nih.gov/40529812/). *Front Genet*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 10:43 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Lab test results | 6 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Decreased activity of mitochondrial complex II, Decreased activity of mitochondrial complex III |
Blood and immune system | 3 | Low red blood cell count (anemia), Sideroblastic anemia, Low white blood cell count (decreased total leukocyte count) |
Brain and nerves | 2 | Exercise intolerance, Difficulty walking (gait disturbance) |
Eyes | 1 | Bilateral ptosis |
Bones and joints | 1 | Skeletal muscle atrophy |
Lungs and breathing | 1 | Dyspnea |